Clinical Report: Molecular Patterns Associated with Damage in Hepatic Ischemia-Reperfusion Injury

Overview

This report discusses the role of damage-associated molecular patterns (DAMPs) in hepatic ischemia-reperfusion injury (HIRI), emphasizing their potential as biomarkers for early allograft dysfunction and biliary complications. The review highlights the spatiotemporal dynamics of DAMP release and their implications for therapeutic strategies in liver transplantation.

Background

Hepatic ischemia-reperfusion injury (HIRI) is a significant clinical challenge that can lead to early allograft dysfunction and complications following liver transplantation. Understanding the molecular mechanisms underlying HIRI, particularly the role of DAMPs, is crucial for improving patient outcomes and expanding the use of marginal donor grafts. The identification and application of DAMPs as biomarkers could enhance injury assessment and guide therapeutic interventions.

Data Highlights

No numerical data or trial data available in the source material.

Key Findings

• DAMPs play a central role in mediating sterile inflammation during HIRI.
• Different classes of DAMPs are released at specific phases of ischemia and reperfusion, impacting injury severity.
• Circulating and perfusate-accessible DAMP signatures can serve as minimally invasive tools for injury grading and risk stratification.
• Therapeutic strategies targeting DAMPs include limiting their release and enhancing their clearance.
• Barriers to clinical translation of DAMP-based biomarkers include assay heterogeneity and the need for multicenter validation.

Clinical Implications

Clinicians should consider the role of DAMPs in assessing liver injury and predicting complications in liver transplantation. Implementing DAMP-targeted strategies may improve graft outcomes and facilitate the use of marginal donor organs. Ongoing research is needed to standardize DAMP assays and validate their clinical utility.

Conclusion

A DAMP-centered framework offers a promising approach to connect molecular injury biology with clinical decision-making in liver transplantation. Further studies are essential to translate these findings into practice.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- The immune-cardiovascular metabolic circuitry in myocardial ischemia-reperfusion injury: from metabolic signal release to spatiotemporal reprogramming
2. Basic Research in Cardiology, 2026 -- Exploring Ischemia/Reperfusion Injury and Cardioprotection: Overlooked and Novel Pathways and Therapeutic Avenues for Tailored Treatment
3. Archives of Toxicology, 2015 -- Biomarkers for Assessing Acute Liver Damage Induced by Acetaminophen
4. EASL Clinical Practice Guidelines on liver transplantation, 2024 -- ScienceDirect
5. Archives of Toxicology — Metabolomic Profiling for Differentiating Phenotypes of Drug-Induced Liver Injury (DILI)
6. The 2024 ILTS-ILCA consensus recommendations for liver transplantation for hepatocellular carcinoma and intrahepatic cholangiocarcinoma
7. Consensus classification of biliary complications after liver transplantation: guidelines from the BileducTx meeting
8. Consensus Statement: Technical Standards for Thoracoabdominal Normothermic Regional Perfusion
9. EASL Clinical Practice Guidelines on liver transplantation - ScienceDirect
10. Hepatology
11. A French multicenter randomized controlled trial of hypothermic oxygenated perfusion in extended criteria donor liver transplantation - ScienceDirect
12. Long-term Follow-up After Hypothermic Oxygenated Machine Perfusion in DCD Liver Transplantation: Results of a Randomized Controlled Multicenter Trial (DHOPE-DCD).
13. Hypothermic Machine Perfusion Of Liver Allografts: State Of The Art | Current Transplantation Reports | Springer Nature Link
14. Disulfide-HMGB1 Drives Ischemia-Reperfusion Injury in Human Liver Transplantation - PMC
15. Perfusate Liver Arginase 1 Levels After End-Ischemic Machine Perfusion Are Associated with Early Allograft Dysfunction | MDPI
16. Primary cilia as a targetable node between biliary injury, senescence and regeneration in liver transplantation - ScienceDirect